Literature DB >> 10487570

Benign parotid hypertrophy on +HIV patients: limited late failures after external radiation.

J J Beitler1, R V Smith, A Brook, M Edelman, A Sharma, M Serrano, C E Silver, L W Davis.   

Abstract

PURPOSE: Although 8-10 Gy of external radiation therapy for +HIV associated parotid hypertrophy has achieved high response rates, the responses were transient with only 1/12 of patients retaining cosmetic control at median follow-up procedures of 9.5 months. Retreatment for failures after 8-10 Gy has also been unsatisfactory. Having shown that 24 Gy of external radiation therapy for benign parotid hypertrophy produced more durable cosmetic control than 8-10 Gy, we now report on longer follow-up periods on a group of patients receiving 24 Gy.
MATERIALS AND METHODS: Twenty +HIV patients with clinical and radiographic evidence of lymphoepithelial lesions of the parotid were treated with 24 Gy of external radiation therapy using daily 1.5 Gy fractions; parallel opposed technique and 6 MV photons were used in 19 patients, and unilateral electron treatment was performed for one patient.
RESULTS: With a mean follow-up period of 24 months, the cosmetic control appears durable. We have had no late failures past 24 months. Two patients have complained of modest xerostomia. There was no correlation with size of the cyst and eventual cosmetic result.
CONCLUSIONS: Twenty-four Gy produces durable parotid control for HIV associated lymphoepithelial lesions of the parotid glands in +HIV patients. Failures after 2 years are uncommon and the side effects have been tolerable.

Entities:  

Mesh:

Year:  1999        PMID: 10487570     DOI: 10.1016/s0360-3016(99)00179-0

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  5 in total

1.  Management algorithm for HIV-associated parotid lymphoepithelial cysts.

Authors:  Waleed F Mourad; Shyamal Patel; Rebekah Young; Azita S Khorsandi; Catherine Concert; Rania A Shourbaji; Katherine Ciarrocca; Richard L Bakst; Daniel Shasha; Chandan Guha; Madhur K Garg; Kenneth S Hu; Shalom Kalnicki; Louis B Harrison
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-02-16       Impact factor: 2.503

2.  Apparent diffusion coefficient mapping of the normal parotid gland and parotid involvement in patients with systemic connective tissue disorders.

Authors:  Rahul R Patel; Ruth C Carlos; Mehran Midia; Suresh K Mukherji
Journal:  AJNR Am J Neuroradiol       Date:  2004-01       Impact factor: 3.825

3.  Low dose radiotherapy for adenotonsillar lymphoid hyperplasia in HIV-positive patients.

Authors:  J Grobbelaar; Riaz Y Seedat; A J Claassen; L Goedhals; M Nel
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-01-05       Impact factor: 2.503

4.  Benign lymphoepithelial cysts of the parotid: long-term surgical results.

Authors:  Matthew K Steehler; Mark W Steehler; Steven P Davison
Journal:  HIV AIDS (Auckl)       Date:  2012-05-28

Review 5.  Oral complications of HIV disease.

Authors:  Jair C Leao; Camila M B Ribeiro; Alessandra A T Carvalho; Cristina Frezzini; Stephen Porter
Journal:  Clinics (Sao Paulo)       Date:  2009-05       Impact factor: 2.365

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.